KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Gains from Investment Securities (2016 - 2026)

Globus Medical filings provide 10 years of Gains from Investment Securities readings, the most recent being -$92.2 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 3617.25% to -$92.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$86.5 million, a 92.22% decrease, with the full-year FY2025 number at $2.9 million, down 73.46% from a year prior.
  • Gains from Investment Securities hit -$92.2 million in Q4 2025 for Globus Medical, down from $2.2 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $31.8 million in Q4 2021 to a low of -$92.2 million in Q4 2025.
  • Median Gains from Investment Securities over the past 5 years was $2.6 million (2024), compared with a mean of -$685900.0.
  • The widest YoY moves for Gains from Investment Securities: up 1489.7% in 2025, down 3617.25% in 2025.
  • Globus Medical's Gains from Investment Securities stood at $31.8 million in 2021, then crashed by 38.71% to $19.5 million in 2022, then tumbled by 379.45% to -$54.6 million in 2023, then soared by 104.8% to $2.6 million in 2024, then plummeted by 3617.25% to -$92.2 million in 2025.
  • The last three reported values for Gains from Investment Securities were -$92.2 million (Q4 2025), $2.2 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.